Cancer's molecular sweet tooth and the Warburg effect

被引:970
作者
Kim, Jung-whan
Dang, Chi V.
机构
[1] Johns Hopkins Univ, Sch Med, Div Hematol, Dept Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr John Hopkins, Baltimore, MD USA
关键词
D O I
10.1158/0008-5472.CAN-06-1501
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
More than 80 years ago, the renowned biochemist Otto Warburg described how cancer cells avidly consume glucose and produce lactic acid under aerobic conditions. Recent studies arguing that cancer cells benefit from this phenomenon, termed the Warburg effect, have renewed discussions about its exact role as cause, correlate, or facilitator of cancer. Molecular advances in this area may reveal tactics to exploit the cancer cell's "sweet tooth" for cancer therapy.
引用
收藏
页码:8927 / 8930
页数:4
相关论文
共 20 条
[11]   Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis [J].
Li, F ;
Wang, YY ;
Zeller, KI ;
Potter, JJ ;
Wonsey, DR ;
O'Donnell, KA ;
Kim, JW ;
Yustein, JT ;
Lee, LA ;
Dang, CV .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (14) :6225-6234
[12]   p53 regulates mitochondrial respiration [J].
Matoba, Satoaki ;
Kang, Ju-Gyeong ;
Patino, Willmar D. ;
Wragg, Andrew ;
Boehm, Manfred ;
Gavrilova, Oksana ;
Hurley, Paula J. ;
Bunz, Fred ;
Hwang, Paul M. .
SCIENCE, 2006, 312 (5780) :1650-1653
[13]   HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption [J].
Papandreou, I ;
Cairns, RA ;
Fontana, L ;
Lim, AL ;
Denko, NC .
CELL METABOLISM, 2006, 3 (03) :187-197
[14]   Akt-dependent transformation: there is more to growth than just surviving [J].
Plas, DR ;
Thompson, CB .
ONCOGENE, 2005, 24 (50) :7435-7442
[15]  
Powers JT, 2004, MOL CANCER RES, V2, P203
[16]   Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements [J].
Rarnanathan, A ;
Wang, C ;
Schreiber, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (17) :5992-5997
[17]   Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase [J].
Selak, MA ;
Armour, SM ;
MacKenzie, ED ;
Boulahbel, H ;
Watson, DG ;
Mansfield, KD ;
Pan, Y ;
Simon, MC ;
Thompson, CB ;
Gottlieb, E .
CANCER CELL, 2005, 7 (01) :77-85
[18]   Targeting HIF-1 for cancer therapy [J].
Semenza, GL .
NATURE REVIEWS CANCER, 2003, 3 (10) :721-732
[19]   ORIGIN OF CANCER CELLS [J].
WARBURG, O .
SCIENCE, 1956, 123 (3191) :309-314
[20]  
Xu RH, 2005, CANCER RES, V65, P613